Hello!
David Johnston CFO
David Johnston CFO has over thirty years of senior financial leadership experience
About Me
David Johnston, CFO, brings over thirty years of senior financial leadership experience. Currently, David Johnston, CFO, is principal of dbj Consulting LLC, providing financial and strategic advice to emerging life science companies.
Learn MorePortfolio
David Johnston CFO Portfolio
Recent News
June 26, 2022
Biotechnology Applications
David Johnston CFO pointed out that, We’ve all heard about genetically modified crops, edible vaccines, and translational medicine, but do we really understand the applications of biotechnology? Here are some examples: Translational medicine by David Johnston CFO There are many functional interactions required in translational medicine, and the process of translating discoveries into […]
June 3, 2022
Medical Biotechnology Education Requirements and Employment Outlook
Medical Biotechnology Education Requirements and Employment Outlook – David Johnston CFO According to David Johnston CFO, careers in medical biotechnology are rapidly growing in popularity. Here are the requirements for these fields, as well as the employment outlook. Reading your DNA seems like a huge privacy breach. Imagine your doctor is reading your DNA and […]
May 23, 2022
Career Options For Those With a Life Science Degree
A life science degree can open up many opportunities for you. The study of life sciences includes a variety of disciplines, including cell biology, physiology, ecology, and pharmacology. While many life science majors choose to continue their education and seek graduate study, the four-year degree can help you gain valuable skills that employers value. There […]
May 11, 2022
The Life Sciences Industry and Its Prospects for the Future
When it comes to talent and financial cash, New York City is quickly becoming a life sciences hotspot, rivaling Boston in terms of importance. The competition in New York City, on the other hand, may make it difficult to close deals. A record amount of venture capital money has been invested in bio sciences start-up […]